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Abstract
Atopy is an inherited tendency of producing immunoglobulin E on common 
proteins from the environment like pollen, house mites and food. The presence of 
atopy represents a risk for the development of allergic diseases like atopic derma-
titis, asthma, allergic rhinitis and food allergy, although atopy can also be present 
only in the form of asymptomatic sensitization. Allergic diseases share common 
inherited and environmental risk factors, immunologic patterns of allergen-specific 
Th2 response and efferent phase of immunologic reaction characterized with the 
production of IgE and activation of granulocytes. The presence of one disease 
increases the risk for developing other diseases. Allergic diseases demonstrate 
characteristic sequence of incidence in childhood which is called allergic/atopic 
march and starts with atopic dermatitis in early infancy. Disrupted integrity of 
the skin in atopic dermatitis contributes to the development of sensitization and 
increases the risk for development of other allergic diseases. The discovery of filag-
grin gene mutation opens the possibility for causative incidence of allergic diseases 
and for prevention of development of atopic march. But, the causal link from atopic 
dermatitis to asthma is still a matter of debate.
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1. Introduction
Allergic diseases are the most common chronic condition in childhood. 
Epidemiological studies observed increase in the prevalence of allergic diseases 
from the middle of the twentieth century, which is explained by environment 
and lifestyle changes and improvements in modern Westernized societies. At the 
beginning of the twenty-first century, stagnation in the prevalence of asthma 
while increase in the prevalence of food allergy was noticed, which announced 
the second wave of allergy epidemics [1–3]. The first atopic phenotype that starts 
in early infancy is atopic dermatitis (AD). It is estimated that it affects up to 20% 
of children. Disrupted integrity of the skin barrier contributes to the develop-
ment of sensitization to food and aeroallergens and also increases the risk for the 
development of food allergy. It is considered that 30% of children with AD have 
food allergy, and 30% develop asthma and 75% allergic rhinitis [4]. About 3–5% of 
children have been diagnosed with food allergy, and up to 50% of them have AD 
[1]. AD and food allergy can coexist and can also appear independently in infancy 
and in the first years of life. In the following years, wheezing induced by viruses like 
respiratory syncytial virus or rhinovirus and sensitization to inhalational allergens 
can be observed. As the child grows up, respiratory symptoms are more common 
and occur outside of the infection; introduction of anti-inflammatory drugs is 
needed, i.e., the signs of asthma occur. Preschool and school age are the time of 
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appearance of allergic sensitization to pollen of grass, weed and tree pollen, and 
the beginning of allergic rhinoconjunctivitis which persists in adolescence and the 
young adult age.
At the same time, remission of atopic dermatitis and food allergy is noticed, while 
asthma and rhinitis symptoms continue. Sensitizations to pollen and cross-reactions 
to nuts, fresh fruits and vegetables may induce oral allergy syndrome, the type of 
food allergy that occurs in the school age. Asthma may disappear in teenage years, 
but after some period of remission, skin and respiratory symptoms can appear once 
again. In early adulthood, skin and lung symptoms are related to tobacco smoking, 
occupational exposures and lifestyle, and they manifest like contact dermatitis or 
asthma-chronic obstructive pulmonary disease overlap syndrome [5].
Atopic dermatitis, food allergy, asthma and allergic rhinitis in childhood share 
the common genetic, epigenetic and environmental risk factors, while the under-
pinning pathogenesis is marked with disrupted skin, lung and gut barriers, altered 
microbiome and local and systemic Th-2-driven immunological pathways. Those 
allergic conditions can comanifest or occur in temporal sequence. The hypothesis 
that has been proposed to clarify time sequence and associations of allergic disease 
is called allergic march. This concept means that allergic disorder starts in early 
infancy with the first hallmark of atopy and atopic dermatitis and then appears 
food allergy, and later in childhood comes asthma and allergic rhinitis. Some 
investigators presumed that the underlying allergic inflammation of the skin could 
progress from atopic dermatitis to asthma. In addition, some preventive measures 
like improving skin barrier before skin disease onset can reduce the risk for respira-
tory allergy. Those observations support the causal link between atopic dermatitis 
and asthma. Although described longitudinal appearance of all allergic diseases was 
noticed only in small proportion (~7%) of children [6, 7], others had different tra-
jectories of one or more allergic diseases which can occur in different point of time 
in childhood. Last explanations are talking about a cluster of coexistence-related 
allergic diseases rather than a progression.
2.  Atopic dermatitis, disrupted skin barrier and allergic sensitization: is 
it the beginning?
Atopic dermatitis is the most common chronic skin disorder in childhood. It 
appears in early childhood with dry, itchy skin and eczema on the cheeks, wrists 
and other parts of the body. Up to 20% of children experience AD in childhood. The 
majority outgrows eczema, but one proportion of them continues to have symptoms 
into adulthood [8]. According to the recently published cohort, six latent classes 
representing subphenotypes of AD were identified. These classes can be sum-
marized in four classes as follows: unaffected individual or transient AD (61.9%); 
early-onset-persistent AD (10.7%); early-onset late resolving, early-onset early 
resolving and mid-onset resolving by age 11 years of age (16.5%); and later-onset 
AD after age 3.5 years (10.9%) [9].
AD is a systemic disorder characterized by disrupted skin barrier. It is consid-
ered that factors associated with damage of skin barrier are complex and influenced 
by a combination of structural, genetic, environmental and immunological factors. 
Structural changes are caused by altered lipid composition, decreased structural 
proteins, increased skin pH and reduced skin microbiome diversity. Cutaneous per-
meability defects can be assessed by measuring transepidermal water loss (TEWL) 
which correlates with disease severity. Several genetic defects encoding skin barrier 
proteins contribute to the breakdown of skin barrier. Inherited loss-of-function 
mutations in filaggrin gene, which encodes structural epidermis proteins, are 
3Allergic March
DOI: http://dx.doi.org/10.5772/intechopen.85553
associated with early-onset AD that is more often persistent and closely related with 
asthma and food allergy [10]. Polymorphisms in the thymic stromal lymphopoietin 
(TSLP) gene, SPINK5 gene and corneodesmosin have also been linked to AD and 
the development of food allergy [11–13]. The inflammatory responses induced by 
AD are manifested by increased production of Th2 cytokines such as IL-4, IL-13, 
IL-25, IL-33 and TSLP. TSLP is one of the major inductors of systemic Th2 response, 
and it is considered that it could be the link between skin and respiratory allergy. 
It is expressed in skin keratinocytes, pulmonary airway and intestinal epithelium, 
while increased expression was observed in the skin of AD patients and respiratory 
epithelium of asthma patients [14].
Skin microbiome dysbiosis is characterized by the dominance of Staphylococcus 
aureus which through various mechanisms worsens chronic skin inflammation [15]. 
Skin barrier dysfunction is associated with innate immune activation that results 
in dysregulated immune response to environmental antigens (like allergens and 
bacteria) and skin inflammation leading to the evolution of allergic sensitization 
[16]. Several studies on animals and humans support the concept that damaged skin 
promotes sensitizations. In mouse, exposure to egg and peanuts through disrupted 
skin induces sensitization [17] and, after exposure to egg aerosol, could induce 
asthma-like airway hyperresponsiveness [18]. In children, applications of peanut 
oil to inflamed skin were positively associated with the development of peanut food 
allergies [19], and the use of wheat-containing facial soap was positively associated 
with the development of wheat food allergy [20]. Application of oat-based creams 
on the skin of children with AD can induce oat sensitization in one third of children 
[21]. The concept of allergic march has been supported by cross-sectional and 
longitudinal birth cohort studies. Several birth cohorts have shown associations 
between early-onset AD and development of asthma and allergic rhinitis in school 
age [22, 23]; risk is greater in children with early-onset persistent AD phenotype 
[24]. Children with AD and allergic sensitization had increased risk of food allergy, 
asthma and allergic rhinitis compared to non-sensitized children without AD [25]. 
Food sensitizations in the first 2 years of life were associated with increased risk of 
asthma and allergic rhinitis in school age [26]. Peanut, milk and egg food allergy 
also increased the risk of developing asthma and rhinitis later in childhood [27]. 
Meta-analyses of birth cohort studies which investigated atopic march observed 
that early-life food sensitization was associated with an increased risk of infantile 
eczema, childhood wheeze/asthma, eczema and allergic rhinitis and young adult 
asthma [28].
The development of sensitization is complex, and except skin barrier defect and 
environmental allergen exposure, the presence of other factors is important because 
they may function as adjuvants, and some of them are bacterial colonization of the 
skin, allergens with intrinsic protease activity and exogenous adjuvants [29].
3. Why is allergy increasing? Hypothesis-driven strategy
Allergic diseases of the skin, gut and lung are complex disorders with multiple 
phenotypes and underlying genotypes. They occur as a result of environmental 
exposures during early life in individuals with genetic susceptibility to allergy. 
Gene-environment interactions are accountable for different influences of the 
environment on individual level. There are several hypotheses of allergy increase 
in the twentieth century. According to the hygiene hypothesis, decreased exposure 
to microorganisms in modern society, through increased hygiene and decreased 
prevalence of infection in early life, disrupts immune tolerance and directs immu-
nological reaction toward Th2 direction [30].
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The beginning of hygiene hypothesis can be found in the David Strachan study 
from 1989. He observed that children who grew up in large families, with large 
number of older siblings, have less allergy and concluded that exposure to infection in 
early life (prenatally and early childhood) can prevent allergy [31]. This was con-
firmed by subsequent studies which linked less allergies with viral, bacterial or proto-
zoic pathogens, transmitted by the fecal-oral route [32]. In 1990 hygiene hypothesis 
was supported by the observation that growing up on farms, regular contact with 
farm animals, stables and drinking unpasteurized milk were protective against allergy 
[33]. Farms are microbe-rich environment. Endotoxin, lipopolysaccharide, part of 
the outer layer of Gram-negative bacteria, is a marker of microbe surroundings. Its 
protective effect on atopy is produced by stimulation of immune system in Th1 direc-
tion. Preventive effect of endotoxin was seen only for early-life exposure (prenatal 
and early childhood, before development of allergic sensitization) [33, 34].
In the past 20 years, hygiene hypothesis was expanded by “old friends hypoth-
esis” and “biodiversity hypothesis” [35, 36]. According to that hypothesis, con-
tact with natural environment and its species (included microbes and parasites) 
protects against allergy. Children are exposed to the environment indirectly 
(through mother during prenatal life) and directly through the skin, gut and 
lung. Changes in the microbiome of the gut, skin and nose reduced microbiome 
diversity, and loss of symbiotic relationship with parasites and bacteria increased 
the risk for allergic disease [37]. Stability and diversity of gut microbiome are 
developed during early life (first 1000 days of postnatal life). This process can be 
influenced with different factors like mode of birth, infant feeding, fiber content 
in the mother’s and child’s diet and older siblings and exposure to pets and/or 
farm animals during childhood. Environment and dietary habits of mother and 
previous generations can change microbe diversity of neonate’s trough epigenetic 
modification [38–42].
The second hypothesis dual-allergen exposure hypothesis is based on observations 
that allergic sensitization occurs through disrupted skin in AD, while early ingestion 
of food (before development of sensitization) allows development of oral toler-
ance [43]. Delayed introduction of solid food in infancy, which were recommended 
at the end of the twentieth was not protective for food allergy development [44]. 
This hypothesis was confirmed by several randomized clinical trials like Learning 
Early About Peanut Allergy (LEAP) and Enquiring About Tolerance (EAT). EAT 
was looking at the early introduction of six common food allergens at 3 months of 
age alongside breastfeeding compared to exclusive breastfed infants. It found that 
prevalence of egg allergy was lower among infants with early introduction [45]. 
LEAP assessed oral tolerance induction of peanut in group of high-risk infants 
between 4 and 11 months of age. It compared early and regular peanut consump-
tion, average of 6 grams of peanut protein a week, in relation to completely avoiding 
peanut protein until 60 months of age. Early introduction of peanut protein results 
in significant reduction in peanut allergy. LEAP-On study was an extension of LEAP, 
in which protective effect of early introduction on peanut allergy was observed, even 
after cessation of peanut consumption [46, 47]. According to the findings from the 
studies like LEAP and EAT, guidelines for complementary feeding were remarkably 
changed. Pediatric and allergy societies have published consensus statements about 
early introduction of peanuts in high-risk infants. Also, current recommendations 
advise against delayed introduction of allergenic food into infant diet [48, 49].
Recent researches report about the important role of vitamin D in the pathogen-
esis of allergy. Vitamin D has positive impact on foetal lung development and an 
immunomodulatory effect; it stimulates differentiation of T lymphocytes, induction 
of Treg, while its deficiency induces Th2 response [50]. It was observed that rise 
in allergy prevalence occurs with increasing vitamin D deficiency especially among 
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populations less exposed to the sun [51]. Deficit of vitamin D is associated with 
increased risk of peanut and egg food allergy, atopic dermatitis and asthma. The 
severe form of the diseases was observed with higher vitamin D deficiency [52, 53].
4. Allergic march: causal link or cluster of related diseases
The allergic march is a real phenomenon, but there is a great debate about 
underlying mechanisms. Some researchers argue that there is a causal link between 
AD and other allergic diseases in childhood, in which AD is the first disease with 
local and systemic immunological response. Systemic response could trigger 
multisystem allergic disease. Longitudinal, prospective population-based cohorts 
or cohorts of high-risk infants reported about increased risk of asthma and allergic 
rhinitis among children with previous or current AD [54–59].
Meta-analysis of 13 prospective birth cohort studies reported that odd ratio 
of asthma among children with AD in the first 4 years of life was 2.14% (95% CI 
1.67–2.75), while the prevalence of asthma at the age of 6 years in eczema cohort 
studies was 29.5% (95% CI, 28.2–32.7%). The conclusion was that only one in 
every three children with eczema develops asthma during later childhood [4]. 
According to the results of high-risk birth cohort, 26.7% children with AD devel-
oped AR at 7 years of age, while the risk is higher among children with persistent 
and late-onset AD (OR 2.68, 95% CI 0.97–7.41) [57]. Sensitization to food allergen 
increased the risk for AR (OR 1.2, 95% CI 0.6–2.2), but the associations is stron-
ger among children who had co-sensitization to both food and aeroallergens (OR 
3.1, 95% CI 1.2–7.8) [28]. In the PASTURE study, children with early-persistent 
AD phenotype and those with late phenotype had an increased risk of developing 
allergic rhinitis. Early AD phenotype did not associate with AR, while the risk 
increased among children with early AD and food allergy [60]. According to these 
results, there was a new question: can we predict which phenotype of AD will 
be linked to asthma? More information come from longitudinal cohorts which 
analyzed different phenotypes of AD based on disease course and determined 
which classes are at highest risk for other atopic diseases [9, 60, 61]. According 
to the results from those studies, the early-onset, severe, persistent phenotype 
is associated with the highest risk for allergic comorbidities. Polysensitization, 
atopic heredity and filaggrin loss-of-mutation contribute to increased risk [62]. 
Children with high-risk phenotype of AD are candidates for preventive measures, 
which could delay or stop the occurrence of asthma and allergic rhinitis. But, it is 
considered that there is not enough evidence that AD causes asthma and allergic 
rhinitis. Paller et al., in recent review, presumed existence of inherited predis-
position to one or more atopic disorders. Occurrence of the disease is a result of 
complex interplay between different underlying genotypes and environmental 
exposures during maturation of immune system, with tissue-specific peak time of 
clinical manifestation. Allergic diseases have different phenotypes and different 
trajectories that form clusters [62].
Simultaneously with AR, local allergic rhinitis (LAR) can appear in the pre-
school age. This entity of rhinitis is marked with local synthesis of specific IgE but 
without systemic allergy (allergic sensitizations and specific IgE). It was observed 
that LAR is a separate, well-defined phenotype of noninfectious rhinitis, which 
is stable over time [63, 64]. But, among younger patients and children, LAR can 
be the first step in the natural evolution to classical AR, especially when starting 
in the first two decades of life and in polysensitized patients [65]. In the German 
Multicentric Allergy Study, it was observed that over one third of the children 
developing a typical grass pollen-related seasonal AR had no serum-specific IgE 
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to pollen. These children develop a systemic IgE sensitization to grass pollens in the 
second or third pollen season following the onset of their rhinitis symptoms [66, 67]. 
If patients with LAR have AR over time, this supports atopic march.
5. Can we prevent and/or stop atopic march?
Better understanding of underpinning mechanisms of atopic dermatitis 
and atopic comorbidities as well as environmental risk factors induces further 
researches of preventive interventions aimed at stopping atopic march. Those 
interventions could be started during pregnancy and early life among healthy or 
high-risk infants before onset of disease (primary prevention) or among children 
with one atopic disease in order to prevent appearance of other atopic comorbidities 
(secondary prevention).
Disrupted skin barriers promote sensitizations and increase the risk for allergic 
disease. Improvement in skin barrier through regular application of emollients 
beginning in the neonatal period can prevent AD among high-risk children. 
Protective effect was observed if treatment lasted up to 6–8 months of age [68–70]. 
There was favorable effect at the 12 months of age, even after treatment was ceased 
[69]. These researches support original hypothesis of skin barrier dysfunction as 
a beginning of atopy march, but it is still unclear if this protective effect is long-
lasting or onset of AD is delayed. The effect of emollients on food allergy was 
unclear. Only one research showed a trend for decreased food sensitization at 6 and 
12 months of age [69], while two other were not powered to measure food sensitiza-
tion [68, 70]. Some of undergoing studies aim to investigate the effect of emollients 
in prevention of AD among general population.
Local and system inflammatory response is a hallmark of AD, and anti-inflam-
matory therapy is effective in control of exacerbations, but study of Schneider et al. 
showed ineffectiveness of pimecrolimus in stopping atopic march [71]. Skin micro-
biome dysbiosis can increase the risk for onset or exacerbation of AD and comor-
bidities [72]. Recent researches showed that topical application of skin commensal 
bacteria can improve lesions in AD [73, 74]. Apart from local use of bacteria, the 
great interest of researchers is the role of probiotics in protection of allergy. Several 
studies have shown positive effect of probiotics like that adding Lactobacillus rham-
nosus in diet of pregnant women can reduce the risk of AD [75]. Adding probiotics 
like Bifidobacterium lactis, Lactobacillus salivarius or Lactobacillus GG to the infant 
formula reduced the severity of AD [76]. But recent randomized control trial has 
shown opposite result. The study concluded that early supplementation with LGG 
in the first 6 months of life does not appear to prevent eczema at 2 years of age [77]. 
However, systematic reviews and meta-analyses report protective effect of the 
probiotics for the primary prevention of atopic dermatitis [78–80]. Probiotics are 
ineffective in prevention of asthma, food allergy and allergic rhinitis. Medical soci-
eties like the American Academy of Pediatrics, the European Academy of Allergy 
and Clinical Immunology and the European Society for Pediatric Gastroenterology, 
Hepatology and Nutrition do not recommend the use of probiotics for primary 
prevention of allergic disease [49, 81–83]. The World Allergy Organization recom-
mends the use of probiotics in diet of mothers of high-risk infants during preg-
nancy and lactation and in diet of those infants in order to prevent AD [84]. There is 
no consensus for the most effective specific strain of probiotics. The strain, dosage, 
timing of introduction and duration of probiotics usage are still uncertain. These 
questions are the aim of the future investigations.
Early introduction of allergenic food like peanut and egg can prevent food 
allergy, but the effect on other allergic diseases is not known. Exposure to furry pets 
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in home like dogs and cats in early life can prevent sensitization, but this protective 
effect can be modified by endotoxin exposure [85]. Deficiency of vitamin D has 
been associated with onset and exacerbation of allergy. According to this immuno-
modulatory effect, it has been assumed that supplementation of vitamin D might 
protect against allergy. But recent researches does not support protective role of 
vitamin D in allergy [86, 87].
In the prevention of allergic diseases, protective effect was observed for anti-
histamines. In infants with atopic dermatitis or with high risk for allergy, ketotifen 
treatment was associated with lower incidence of asthma [88], while the use of 
cetirizine decreased the risk for asthma in grass pollen-sensitized children [89]. 
Allergen immunotherapy (AIT) has been used over the last 100 years and is the 
only therapy with disease-modifying effect. The role of AIT in primary and second-
ary prevention was investigated in several studies. Sublingual AIT applied for the 
primary prevention of allergy among high-risk infants has no protective effect on 
the developing of first allergic disease [90]. Oral AIT decreased the risk of asthma, 
among children with grass pollen allergic rhinitis [91]. Recent systematic review 
and meta-analysis found no evidence that AIT decreased the risk for developing 
a first allergic disease. However, AIT reduced the risk of asthma among patients 
with allergic rhinitis. This effect was observed 2 and more years after the AIT was 
completed. AIT can reduce the onset of new sensitizations, but the evidence was 
not clear [92, 93].
6. Conclusion
Allergic diseases like atopic dermatitis, asthma and allergic rhinitis have sequen-
tial appearance with typical peaks of incidence during childhood. This temporal 
association is observed in the whole children population, and it starts with atopic 
dermatitis and food allergy in infancy, followed with asthma in the preschool age 
and finishes with allergic rhinitis. During growing up, the remission of atopic der-
matitis and asthma was noticed, while symptoms of allergic rhinitis persist through 
adolescence and young adult age. The occurrence of all allergy diseases among 
the same child in temporal appearance was noticed only in smaller proportion of 
children in which causal link between AD, asthma and AR can be presumed; while, 
among others, common occurrence of allergic diseases follows different trajectories, 
without typical allergic sequence. For those children, complex interplay of allergic 
predisposition, systemic and local immunological responses and environmental 
influences during maturation of immune system triggers the appearance of those 
coexistence of allergic disease.
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